4.7 Article

From netrin-1-targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors

Related references

Note: Only part of the references are listed.
Review Radiology, Nuclear Medicine & Medical Imaging

Recent Developments in SPECT/CT

Philipp Ritt

Summary: The introduction of multimodal Single Photon Emission Computed Tomography/X-ray Computed Tomography (SPECT/CT) represents an important advancement in Nuclear Medicine imaging, allowing for high-quality image fusion and new clinical applications. Deep-learning approaches are expected to play a significant role in the future of nuclear medicine imaging.

SEMINARS IN NUCLEAR MEDICINE (2022)

Article Gastroenterology & Hepatology

Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation

Romain Barnault et al.

Summary: This study identifies Netrin-1 as an inflammation-inducible factor in the liver and reveals its contribution to hepatic inflammation through an atypical mechanism. Additionally, the study finds that an anti-Netrin-1 antibody has anti-inflammatory activity in hepatic inflammation.

HEPATOLOGY (2022)

Article Multidisciplinary Sciences

Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1

Simon Renders et al.

Summary: Haematopoietic stem cells are characterized by their self-renewal potential and dormancy. This study shows that niche-produced netrin-1 preserves HSC quiescence and self-renewal through neogenin-1, with a decline in netrin-1 production during aging leading to decreased Neo1-mediated HSC self-renewal.

NATURE COMMUNICATIONS (2021)

Article Medicine, Research & Experimental

Targeting netrin-3 in small cell lung cancer and neuroblastoma

Shan Jiang et al.

Summary: Netrin-3 is specifically expressed in neuroblastoma (NB) and small cell lung cancer (SCLC), showing a mutually exclusive expression pattern with netrin-1 in these tumors. Targeting netrin-3 in NB and SCLC may delay tumor growth and improve overall survival based on preclinical studies.

EMBO MOLECULAR MEDICINE (2021)

Review Medicine, Research & Experimental

Dependence receptors: new targets for cancer therapy

Morgan Brisset et al.

Summary: Dependence receptors play a role in promoting cell survival and positive signaling when activated, but trigger apoptosis when unbound to their ligand. Their abnormal regulation in cancer cells allows them to evade apoptosis and promote tumorigenesis, making them potential targets for therapy.

EMBO MOLECULAR MEDICINE (2021)

Article Medicine, General & Internal

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor et al.

Summary: The radioligand therapy with Lu-177-PSMA-617 prolonged both imaging-based progression-free survival and overall survival in patients with PSMA-positive metastatic castration-resistant prostate cancer when added to standard care. Adverse events were more common with Lu-177-PSMA-617 but did not significantly impact quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Chemistry, Medicinal

Targeting of activated fibroblasts for imaging and therapy

Thomas Lindner et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)

Article Chemistry, Multidisciplinary

A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo

Alberto Dal Corso et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Multidisciplinary Sciences

Floor-plate-derived netrin-1 is dispensable for commissural axon guidance

Chloe Dominici et al.

NATURE (2017)

Article Medicine, General & Internal

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

J. Strosberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, Research & Experimental

Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference

Melodie Grandin et al.

EMBO MOLECULAR MEDICINE (2016)

Review Oncology

Dependence Receptors and Cancer: Addiction to Trophic Ligands

Benjamin Gibert et al.

CANCER RESEARCH (2015)

Article Multidisciplinary Sciences

Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance

Duygu Ozmadenci et al.

NATURE COMMUNICATIONS (2015)

Article Oncology

Regulation by miR181 Family of the Dependence Receptor CDON Tumor Suppressive Activity in Neuroblastoma

Benjamin Gibert et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Biochemistry & Molecular Biology

Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity

Bhama Ramkhelawon et al.

NATURE MEDICINE (2014)

Article Medicine, Research & Experimental

Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death

Andrea Paradisi et al.

EMBO MOLECULAR MEDICINE (2013)

Review Oncology

Novel roles for Slits and netrins: axon guidance cues as anticancer targets?

Patrick Mehlen et al.

NATURE REVIEWS CANCER (2011)

Article Immunology

Netrin-1 acts as a survival factor for aggressive neuroblastoma

Celine Delloye-Bourgeois et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Multidisciplinary Sciences

Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer

Julien Fitamant et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)